Patents by Inventor Ahmet Gül

Ahmet Gül has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for the treatment of uveitis with IL-1? binding antibodies
    Patent number: 9139646
    Abstract: Disclosed are methods and materials for inhibiting (e.g., treating or preventing) uveitis in a subject, including treatment refractory uveitis, using anti-IL-1? binding molecules (e.g., IL-1? binding antibodies or binding fragment thereof).
    Type: Grant
    Filed: September 17, 2013
    Date of Patent: September 22, 2015
    Assignee: XOMA (US) LLC
    Inventors: Alan M. Solinger, Ahmet Gül
  • METHODS FOR THE TREATMENT OF IL-1BETA RELATED CONDITIONS
    Publication number: 20140242090
    Abstract: Disclosed are methods and materials for inhibiting (e.g., treating or preventing) uveitis in a subject, including treatment refractory uveitis, using anti-IL-1? binding molecules (e.g., IL-1? binding antibodies or binding fragment thereof).
    Type: Application
    Filed: September 17, 2013
    Publication date: August 28, 2014
    Applicant: XOMA Technology Ltd.
    Inventors: Alan M. Solinger, Ahmet Gül
  • Methods for the treatment of IL-1? related conditions
    Patent number: 8551487
    Abstract: Disclosed are methods and materials for inhibiting (e.g., treating or preventing) uveitis in a subject, including treatment refractory uveitis, using anti-IL-1? binding molecules (e.g., IL-1? binding antibodies or binding fragment thereof).
    Type: Grant
    Filed: May 6, 2011
    Date of Patent: October 8, 2013
    Assignee: Xoma Technology, Ltd.
    Inventors: Alan M. Solinger, Ahmet Gül
  • METHODS FOR THE TREATMENT OF IL-1BETA RELATED CONDITIONS
    Publication number: 20120014966
    Abstract: Disclosed are methods and materials for inhibiting (e.g., treating or preventing) uveitis in a subject, including treatment refractory uveitis, using anti-IL-1? binding molecules (e.g., IL-1? binding antibodies or binding fragment thereof).
    Type: Application
    Filed: May 6, 2011
    Publication date: January 19, 2012
    Applicant: XOMA TECHNOLOGY LTD.
    Inventors: Alan M. Solinger, Ahmet Gül